NDC 70709-156 – Phyrago
Dasatinib 140 mg/1 · Tablet · Oral
Product NDC70709-156
Product details
- Brand name
- Phyrago
- Generic name
- Dasatinib
- Labeler
- Cycle Pharmaceuticals Ltd
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA216099
- Marketed since
- September 22, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Dasatinib 140 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 70709-156-14 | 30 TABLET in 1 BOTTLE (70709-156-14) | Sep 22, 2025 |
Other Phyrago products
- 70709-151 Dasatinib 20 mg/1 · Tablet · Cycle Pharmaceuticals Ltd
- 70709-152 Dasatinib 50 mg/1 · Tablet · Cycle Pharmaceuticals Ltd
- 70709-153 Dasatinib 70 mg/1 · Tablet · Cycle Pharmaceuticals Ltd
- 70709-154 Dasatinib 80 mg/1 · Tablet · Cycle Pharmaceuticals Ltd
- 70709-155 Dasatinib 100 mg/1 · Tablet · Cycle Pharmaceuticals Ltd